基于酸盐的智能水凝的最新进展用于药物输送系统
Aiman Salahuddin1, Azqa Ashraf1, Khurshid Ahmad1
1State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering, Ocean University of China, No.1299, Sansha Road, Qingdao, Shandong Province 266404, PR China.
International journal of biological macromolecules
|October 17, 2024
概括
酸盐水凝提供可持续的药物输送,具有可调节的,对刺激有反应的特性. 来自生物质的材料提高了它们的生物相容性和可控释放,用于各种医疗应用.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 聚合物化学 聚合物化学
背景情况:
- 可持续和可控的药物输送对于有效的疾病治疗至关重要.
- 酸盐水凝具有有利的特性,如调节能力,可控制的降解,以及对药物封装的刺激敏感性.
- 由于其生物降解性和生物相容性,生物质衍生材料越来越受青用于奇多水凝构造.
研究的目的:
- 审查基托水凝的制造方法,性能和生物相容性.
- 探索用于先进药物输送的修改策略和刺激响应机制.
- 讨论基托基智能水凝的潜在应用和未来前景.
主要方法:
- 关于基多水凝制造和表征的综合文献综述.
- 对刺激反应机制 (温度,pH,光等) 的分析. ) 的情况.
- 生物相容性和降解性质的评估.
主要成果:
- 酸盐水凝提供可调节的容量,可控的降解,以及对药物输送的刺激敏感性.
- 生物质衍生的奇托桑水凝具有可生物降解性,生物相容性和无毒性.
- 各种刺激响应机制使药物释放能够微调.
结论:
- 酸盐水凝,特别是来自生物质的水凝,对控制药物输送有希望.
- 具有刺激反应的基托桑水凝在皮下,肠道,口腔和面部输送中提供了多样化的应用.
- 需要进一步的研究来解决临床应用的挑战,并优化未来的智能水凝设计.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
94
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
94
Modified-Release Drug Delivery Systems: Rate-Programmed I
112
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
112
Modified-Release Drug Delivery Systems: Stimuli-Activated
126
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
126
Site-Targeted Drug Delivery Systems: Polymeric Carriers
115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115
Oral Drug Delivery Systems: Continuous-Release Systems
245
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
245
Ophthalmic Drug Delivery Systems
224
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
224


